Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 30;10(17):e37059.
doi: 10.1016/j.heliyon.2024.e37059. eCollection 2024 Sep 15.

Natural products for the treatment of hypertrophic scars: Preclinical and clinical studies

Affiliations
Review

Natural products for the treatment of hypertrophic scars: Preclinical and clinical studies

Yuxiao Zhang et al. Heliyon. .

Abstract

Hypertrophic scarring (HS) is a complication of wound healing that causes physiological and psychological distress in patients. However, the possible mechanism underlying HS is not fully understood, and there is no gold standard for its treatment. Natural products are more effective, economical, convenient, and safe than existing drugs, and they have a wide application prospect. However, there is a lack of literature on this topic, so we reviewed in vivo, in vitro, and clinical studies and screened natural products showing beneficial effects on HS that can become potential therapeutic agents for HS to fill in the gaps in the field. In addition, we discussed the drug delivery systems related to these natural products and their mechanisms in the treatment of HS. Generally speaking, natural products inhibit inflammation, myofibroblast activation, angiogenesis, and collagen accumulation by targeting interleukins, tumor necrosis factor-α, vascular endothelial growth factors, platelet-derived growth factors, and matrix metalloproteinases, so as to play an anti-HS effects of natural products are attributed to their anti-inflammatory, anti-proliferative, anti-angiogenesis, and pro-apoptotic (enhancing apoptosis and autophagy) roles, thus treating HS. We also screened the potential therapeutic targets of these natural compounds for HS through network pharmacology and constructed a protein-protein interaction (PPI) network, which may provide clues for the pharmacological mechanism of natural products in treating this disease and the development and application of drugs.

Keywords: Drug discovery; Hypertrophic scars; Mechanisms; Natural products; Traditional Chinese medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Jing Guo reports financial support was provided by 10.13039/501100001809National Natural Science Foundation of China. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Diagram of the histological features of hypertrophic scars. The formation process of HS involve several cytokines, mediators, cells, and matrix molecules. HS histologically exhibits abundant blood vessels, numerous mesenchymal cells, thickened epidermal cell layer, ECM deposition, and infiltration of lymphocytes, macrophages, and mast cells.
Fig. 2
Fig. 2
Mechanism diagram of natural products acting on hypertrophic scars. Natural products exert various effects such as anti-inflammation, anti-proliferation, inhibition of angiogenesis and pro-apoptotic effects through multiple targets in the wound healing stage, explaining their potential for prevention and treatment of hypertrophic scars.
Fig. 3
Fig. 3
Structural formulae of natural products with HS therapeutic effects.
Fig. 4
Fig. 4
The natural product-target network predicted by network pharmacology. The figure was constructed by Cytoscape 3.6.1. Green circles represent the natural products and the different colored circles represent the targets. The size of the circle representing each node is determined based on the value of betweenness centrality. The color transition from yellow to red indicates the increasing value of betweenness centrality of the targets in the process of HS treatment.
Fig. 5
Fig. 5
The PPI network. The figure was constructed by Cytoscape 3.6.1. The size of the circle representing each node is determined based on the value of betweenness centrality. AHR, AKT1, MTOR, PTGS2, HIF1A, and JUN emerge as the pivotal targets within the network.

Similar articles

Cited by

References

    1. Nabai L., Pourghadiri A., Ghahary A. Hypertrophic scarring: current knowledge of predisposing factors, cellular and molecular mechanisms. J. Burn Care Res. Off. Publ. Am. Burn Assoc. 2020;41:48–56. doi: 10.1093/jbcr/irz158. - DOI - PMC - PubMed
    1. Lv K., Xia Z. Chinese expert consensus on clinical prevention and treatment of scar(+) Burns Trauma. 2018;6:27. doi: 10.1186/s41038-018-0129-9. - DOI - PMC - PubMed
    1. Finnerty C.C., Jeschke M.G., Branski L.K., Barret J.P., Dziewulski P., Herndon D.N. Hypertrophic scarring: the greatest unmet challenge after burn injury. Lancet. 2016;388:1427–1436. doi: 10.1016/S0140-6736(16)31406-4. - DOI - PMC - PubMed
    1. Mahdavian Delavary B., van der Veer W.M., Ferreira J.A., Niessen F.B. Formation of hypertrophic scars: evolution and susceptibility. J. Plast. Surg. Hand Surg. 2012;46:95–101. doi: 10.3109/2000656X.2012.669184. - DOI - PubMed
    1. Poetschke J., Gauglitz G.G. Current options for the treatment of pathological scarring. J. Dtsch. Dermatol. Ges. J. Ger. Soc. Dermatol. JDDG. 2016;14:467–477. doi: 10.1111/ddg.13027. - DOI - PubMed

LinkOut - more resources